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Voluntary HIV testing and
counselling at the workplace —
entirely compatible with the
Employment Equity Act
To the Editor: Previous debate in the SAMJ1-3 drew attention to
the problem (misperceived, in our view) of restrictions placed
on workplace HIV prevention programmes by the provisions
of the Employment Equity Act that prohibit HIV testing at the
behest of employers without permission of the Labour Court.4
The Labour Court recently considered an application by a large
employer in the fishing industry, supported by the employee’s
trade union, to conduct voluntary and anonymous testing for
HIV.5 The ruling of the Labour Court6 found that voluntary
counselling and testing (VCT), an essential element of public
health measures to control HIV, would not require the Court’s
permission. Indeed, the court went further to include
compulsory anonymous HIV testing as permitted without
Labour Court oversight, provided that no discrimination could
result from such testing. Central to the court’s analysis, was the
recognition that voluntary consent removes the testing from
the ambit of the Act, and that no public interest is threatened
by such a waiver of an individual employee’s right to
protective oversight by the Labour Court.
These findings are entirely consistent with guidelines
emanating from the Department of Labour,7 the Department of
Health,8 the Southern African Development Community9 and
the World Health Organisation,10 all of whom recognise the
important contribution that workplace HIV programmes can
make to benefiting employees and the broader objective of HIV
control, an opinion explicitly acknowledged by the Labour
Court in arriving at its finding. We trust that this legal
precedent finally puts to rest the debates circulating regarding
the place of workplace voluntary counselling and testing
programmes in the strategies available for the control of HIV,
misinformation that, in our opinion, can only be of benefit  to
highly paid lawyers and industry consultants, rather than
employees and employers willing to undertake HIV prevention
activities. The message should now go out loudly and clearly
from the public health community — the Employment Equity
Act does NOT prevent the adoption of well-planned non-
discriminatory HIV prevention programmes that include VCT,
and that ensure that participants are able to give informed
consent and to make decisions that benefit their own health
and well-being.
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Breast cancer management in
the new millennium — a
multidisciplinary approach
To the Editor: Breast cancer is the most common cancer in
women worldwide. In South Africa about 5 000 new patients
are diagnosed every year.
Breast cancer is a chronic and unpredictable disease. Over
the past three decades, advances in the knowledge of breast
cancer biology and its different behavioural patterns have
enabled the medical profession to change the management of
this disease. Until the 1970s breast cancer was regarded a loco-
regional disease, with mastectomy being the first treatment of
choice for ‘early’ disease.
Although breast cancer was primarily diagnosed and treated
by surgeons, it is now unacceptable for any single specialty to
manage breast cancer without the input of the other role
players. The roles of the breast radiologist (preoperative
histological diagnosis and extent of disease spread), medical
oncologist (preoperative, and adjuvant treatment, preventive
hormonal and other), nuclear physician (sentinel node
mapping and screening for metastases), breast and
reconstructive surgeon and radiation oncologist are important
in the preoperative workup of all patients. The
mismanagement of breast cancer is eliminated in a
multidisciplinary setting as advocated in leading breast care
centres all over the world. No surgical procedure should be
done at all (surgical excision biopsy included — core needle
biopsy is preferable) before multidisciplinary consultation (in
which the patient herself has a say and time for more
consultation and second opinions). No patient should be
hurriedly pushed into a decision.
It is only since 1992 that there has been a rapid worldwide
decline in breast cancer mortality (in spite of increased
incidence). The progressive advances in early detection using
screening mammography, new techniques in breast surgery,
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plastic surgery and radiotherapy, and finally, new systemic
treatments (hormonal, chemotherapeutic and genetic) have
contributed to many more lives, and breasts, saved.
A Carstens
M A Coccia-Portugal
R Jacobs
Private Bag X19
Menlopark
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Ritalin — on the bandwagon?
To the Editor: The new Ritalin-LA (long acting) was launched
at the beginning of this year at a roadshow throughout the
country. As with many new drugs it became so popular that
almost a month after the launch it was out of stock.
Unfortunately since then I have seen some very worrying
tendencies appear on the horizon. It seems that Ritalin is
increasingly being prescribed without thorough assessment.
One such example involves 4-year-old boy who was put on
Ritalin-LA 30 mg after a complaint by a nursery school teacher
that he could not sit still. Another involves a girl aged 12 years
with sudden regression in school performance and behaviour,
who was put on Ritalin-LA 20 mg, without any response. A full
evaluation revealed that she had been sexually abused.
Another worrying development is that more and more mothers
are phoning to ask for advice after their child has been put on
Ritalin and now has side-effects, with which the prescribing
doctor does not know how to deal.
Ritalin is an excellent and wonderful drug for children who
need it. However, it is my impression that the roadshow
(unintentionally!) might have given the impression to doctors
unfamiliar with the field of developmental paediatrics that the
long-acting version is now a quick fix for concentration
problems. The talk on attention deficit and the functioning of
Ritalin was excellent, but it is important to realise that attention
deficit disorder is only one block in the puzzle of
developmental paediatrics and not the puzzle itself. It is
therefore important to adopt a holistic approach in the case of
the child presenting with concentration problems. This
includes, over and above a full assessment of the main
complaint, a thorough assessment of the child’s emotional
status, social abilities, learning problems, other co-morbid
conditions that might co-exist, and extremely important, also
educational and family psychodynamics. Only when all these
factors are taken into account and fully assessed can a
treatment protocol for each child be individualised and put
into place. If we neglect our duty in this regard we are going
back to the seventies when Ritalin was dished out right, left
and centre — when stopped in those days at 12 years of age,
many children still could not read, write or socialise, and still
struggled with behaviour problems and low self-esteem.
There is also a tendency for children to get referred from
occupational or speech therapists, or even in some instances
from the teacher, with the instruction that the child be put on
Ritalin — and the doctor faithfully obeys.
Professor Johan Prinsloo once said: ‘The most important
thing for a doctor is to know when he does not know.’ I know
that this is general knowledge, but it is still important for any
medical professional to have a sound knowledge of the
functioning and side-effects of any medication that s/he uses
and to have a thorough knowledge and understanding of the
condition being treated. It is in the interests of all children with
developmental problems that they, their families and schools
can rely on correct diagnosis and continuous support. Treating
these children is not a quick prescription, it is a lifelong
commitment.
Johan Erasmus
Moot General Hospital
PO Box 11928
Queenswood
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Weak knees
To the Editor: SAMA online (27 February) reports the South
African Medical Association (SAMA)’s comments on the
pressure from the Board of Health Care Funders (BHC) to force
medical practitioners to contribute to the BHC practitioner
register. SAMA states that discussions with the BHC have been
unsatisfactory in many ways and SAMA said that it wished to
verify and clarify some aspects further.
However, SAMA then goes on to say that it recommends that
all medical practitioners concede to the request, because
‘otherwise they may not get paid’. 
This weak capitulation is not what is expected of SAMA. It
seems that SAMA has no appreciation of its powerful authority.
A directive from SAMA to all medical practitioners,
recommending that payment should be withheld, would stop
short the BHC pressure immediately and so allow all necessary
clarification.
Once a concession is made to the BHC demands, the
precedent will be set, and become irreversible. After this the
BHC will cock a snook at any attempts at further ‘verification
and clarification’.
This additional cost burden, which is of doubtful value to the
individual practitioner, will then become yet another legacy of
weak ineptitude to be inherited by our successors.
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